DrugPatentWatch Database Preview
PROAIR DIGIHALER Drug Profile
Email this page to a colleague
» See Plans and PricingWhen do Proair Digihaler patents expire, and when can generic versions of Proair Digihaler launch?
Proair Digihaler is a drug marketed by Teva Branded Pharm and is included in one NDA. There are seventeen patents protecting this drug.
This drug has three hundred and thirty-two patent family members in thirty-one countries.
The generic ingredient in PROAIR DIGIHALER is albuterol sulfate. There are thirty-eight drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the albuterol sulfate profile page.
US ANDA Litigation and Generic Entry Outlook for Proair Digihaler
A generic version of PROAIR DIGIHALER was approved as albuterol sulfate by SUN PHARM INDUSTRIES on December 5th, 1989.
Summary for PROAIR DIGIHALER
| International Patents: | 332 |
| US Patents: | 17 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Formulation / Manufacturing: | see details |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for PROAIR DIGIHALER |
| DailyMed Link: | PROAIR DIGIHALER at DailyMed |
Pharmacology for PROAIR DIGIHALER
| Drug Class | beta2-Adrenergic Agonist |
| Mechanism of Action | Adrenergic beta2-Agonists |
US Patents and Regulatory Information for PROAIR DIGIHALER
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva Branded Pharm | PROAIR DIGIHALER | albuterol sulfate | POWDER, METERED;INHALATION | 205636-002 | Dec 21, 2018 | RX | Yes | No | Start Trial | Start Trial | Y | Start Trial | |||
| Teva Branded Pharm | PROAIR DIGIHALER | albuterol sulfate | POWDER, METERED;INHALATION | 205636-002 | Dec 21, 2018 | RX | Yes | No | Start Trial | Start Trial | Y | Start Trial | |||
| Teva Branded Pharm | PROAIR DIGIHALER | albuterol sulfate | POWDER, METERED;INHALATION | 205636-002 | Dec 21, 2018 | RX | Yes | No | Start Trial | Start Trial | Y | Start Trial | |||
| Teva Branded Pharm | PROAIR DIGIHALER | albuterol sulfate | POWDER, METERED;INHALATION | 205636-002 | Dec 21, 2018 | RX | Yes | No | Start Trial | Start Trial | Y | Start Trial | |||
| Teva Branded Pharm | PROAIR DIGIHALER | albuterol sulfate | POWDER, METERED;INHALATION | 205636-002 | Dec 21, 2018 | RX | Yes | No | Start Trial | Start Trial | Y | Start Trial | |||
| Teva Branded Pharm | PROAIR DIGIHALER | albuterol sulfate | POWDER, METERED;INHALATION | 205636-002 | Dec 21, 2018 | RX | Yes | No | Start Trial | Start Trial | Y | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for PROAIR DIGIHALER
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Australia | 2001270112 | Start Trial |
| South Africa | 201307991 | Start Trial |
| Poland | 1667627 | Start Trial |
| European Patent Office | 2514463 | Start Trial |
| Peru | 20020163 | Start Trial |
| South Korea | 101471739 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
